Pharmacological management of obesity: an Endocrine Society clinical practice guideline
J. clin. endocrinol. metab; 100 (2), 2015
OBJECTIVE: To formulate clinical practice guidelines for the pharmacological management of obesity. PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. ...
Obésité/traitement médicamenteux, Diabète/étiologie, Dépression/étiologie, Agents sérotoninergiques/usage thérapeutique, Agents dopaminergiques/usage thérapeutique, Norépinéphrine/usage thérapeutique, Phentermine/usage thérapeutique, Bupropion/usage thérapeutique, Naltrexone/usage thérapeutique, Glucagon-like peptide 1/agonistes